Anonymous
Guest
Anonymous
Guest
You guys are idiots. Do the math...Lilly's market cap is $45billion and Astrzeneca is $58billion. For Lilly's board to even consider a sale after being around for over 130 years they would want at least a 30% premium making a sale of $58billion which is what Astrazeneca is worth, meaning ASTRAZENECA CANNOT AFFORD TO BY LILLY. Take an economics or better yet a simple math course and know what you are talking about before posting such absurd things on Cafe Pharma IDIOT....
You are in No Position to call anyone an idiot when you cannot even spell the word BUY. 3 letters. It's not like spelling a word like otorhinolarygology. It's buy!!!!! 3 letters. You are the one in need to take Remedial English!!!